COR vs TECH
Cencora Inc. (COR) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Cencora Inc. (COR) is a medical distribution company listed on NYSE.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported COR revenue for 2025-09-30 was $321.33B. Net income was $1.57B. Revenue was up 9.3% from 2024-09-30 to 2025-09-30. COR currently screens at market cap $53.91B and trailing P/E 21.2.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
COR currently screens at market cap $53.91B and trailing P/E 21.2. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the COR and TECH stock pages for the full models.
Not investment advice.